“Aging should be a continued stage of development and growth, rather than a period of decline.” ~The Eden Alternative Antimicrobial Stewardship. Disease Control & Prevention
Webinar: Defeating Superbugs: Hospitals on the Front Lines Modern Healthcare
About the Webinar: Defeating Superbugs: Hospitals on the Front Lines
http://www.modernhealthcare.com/article/20140917/INFO/309179926
Hospitals across the country are facing a grim reality in which some of the most deadly healthcare-associated infections they encounter are untreatable with first- or even second-line antibiotics. These “superbugs” affect at least 2 million Americans each year and lead to 23,000 deaths. And their threat is growing, public health officials warn. This editorial webinar and “Defeating Superbugs” white paper will explore the steps providers must take to ramp up surveillance efforts, promote appropriate antibiotic use and control outbreaks. Our panel of experts will share their organizations' experiences as well as proven strategies for success.
Registration for this webinar includes Modern Healthcare's “Defeating Superbugs” white paper, with proven tips and strategies for promoting appropriate antibiotic use, improving infection surveillance, identifying drug-resistant infections and dealing with outbreaks.
KEY TAKEAWAYS
- Best practices for effective antimicrobial stewardship
- Real-world examples of effective interventions, including universal rapid testing for drug-resistant MRSA
- Tips for engaging senior leadership
- Aggressive strategies for controlling outbreaks
PANELISTS
Lance Peterson
Director of the Clinical Microbiology and Infectious Disease Research Division
NorthShore University HealthSystem, Evanston, Ill.
Anurag Malani
Medical Director for the Infection Prevention and Antimicrobial Stewardship Programs
St. Joseph Mercy Hospital, Ann Arbor, Mich.
Robert Weinstein
Chief Medical Officer for Population Health
Chairman of the Department of Medicine, Cook County Health and Hospitals System; Professor, Rush University Medical Center, Chicago
MODERATOR
Maureen McKinney
Editorial Programs Manager
Modern Healthcare
Webinar: Defeating Superbugs: Hospitals on the Front Lines Modern Healthcare
About the Webinar: Defeating Superbugs: Hospitals on the Front Lines
http://www.modernhealthcare.com/article/20140917/INFO/309179926
Hospitals across the country are facing a grim reality in which some of the most deadly healthcare-associated infections they encounter are untreatable with first- or even second-line antibiotics. These “superbugs” affect at least 2 million Americans each year and lead to 23,000 deaths. And their threat is growing, public health officials warn. This editorial webinar and “Defeating Superbugs” white paper will explore the steps providers must take to ramp up surveillance efforts, promote appropriate antibiotic use and control outbreaks. Our panel of experts will share their organizations' experiences as well as proven strategies for success.
Registration for this webinar includes Modern Healthcare's “Defeating Superbugs” white paper, with proven tips and strategies for promoting appropriate antibiotic use, improving infection surveillance, identifying drug-resistant infections and dealing with outbreaks.
KEY TAKEAWAYS
- Best practices for effective antimicrobial stewardship
- Real-world examples of effective interventions, including universal rapid testing for drug-resistant MRSA
- Tips for engaging senior leadership
- Aggressive strategies for controlling outbreaks
PANELISTS
Lance Peterson
Director of the Clinical Microbiology and Infectious Disease Research Division
NorthShore University HealthSystem, Evanston, Ill.
Anurag Malani
Medical Director for the Infection Prevention and Antimicrobial Stewardship Programs
St. Joseph Mercy Hospital, Ann Arbor, Mich.
Robert Weinstein
Chief Medical Officer for Population Health
Chairman of the Department of Medicine, Cook County Health and Hospitals System; Professor, Rush University Medical Center, Chicago
MODERATOR
Maureen McKinney
Editorial Programs Manager
Modern Healthcare
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
This Manual of Procedures (MOP) was developed to assist and align the efforts in implementing AMS programs in all (Level I, II, and III) hospitals across the country. It seeks to serve as a guide to individual hospitals in the design and establishment of local AMS programs while providing a framework for national-level action and commitment.
Recommendations within this document are, as far as possible, based on review of published literature on strategies that have shown to be effective. Consultation with key members (Infectious Diseases physicians, clinical pharmacists, and Infection Control nurses) from eight (8) pilot hospitals as well as the National Antibiotic Guidelines Committee (NAGCom), other national Infectious Diseases societies and relevant DOH offices were undertaken to obtain a consensus opinion and ensure that this MOP is practical and feasible.
All attempts to consider the context of local culture and practices have been taken in the creation of this MOP. Nonetheless, we have chosen to only define core aspects of the national AMS program without being overly prescriptive. Hospitals are strongly encouraged to adapt this MOP to their individual setting in order to maximize its effectiveness, including reduce barriers to implementation and encourage shared ownership towards the goal of AMS.
Antibiotic Stewardship: A National and International ImperativePYA, P.C.
J. Michael Keegan, MD, an infectious disease specialist who leads the antibiotic stewardship team at PYA, discussed antibiotic stewardship at the South Dakota Pharmacists Association’s (SDPHA) Annual Convention in Deadwood, South Dakota.
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...John Blue
Metrics and Decision-Making for Antibiotic Stewardship in Human Medicine - Dr. Steve Solomon, Centers for Disease Control & Prevention, Currently serves as Director of the Office of Antimicrobial Resistance in the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, in the Office of Infectious Diseases at CDC., from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Advisor Live: Advancing Antimicrobial StewardshipPremier Inc.
Fight antibiotic resistance! Join us and participate in Get Smart About Antibiotics Week 2016. Medical epidemiologist Dr. Kavita Trivedi will share her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.
- Current regulatory environment
- Implementation tools available
- Implementation challenges
Dr. Ceire Costelloe (Imperial College London) - Data-driven systems medicinemntbs1
The summary of Dr. Ceire Costelloe's presentation from the Jun 11-12th 2019 event Data-driven systems medicine at Cardiff University Brain Research Imaging Centre.
Role of PK PD in Antibiotic Stewardship Program with case study. This presentation gives an comprehensive overview about role of PK PD in antibiotic stewardship program.
Antibiotic Guardian Leeds Workshop 20164 All of Us
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
This Manual of Procedures (MOP) was developed to assist and align the efforts in implementing AMS programs in all (Level I, II, and III) hospitals across the country. It seeks to serve as a guide to individual hospitals in the design and establishment of local AMS programs while providing a framework for national-level action and commitment.
Recommendations within this document are, as far as possible, based on review of published literature on strategies that have shown to be effective. Consultation with key members (Infectious Diseases physicians, clinical pharmacists, and Infection Control nurses) from eight (8) pilot hospitals as well as the National Antibiotic Guidelines Committee (NAGCom), other national Infectious Diseases societies and relevant DOH offices were undertaken to obtain a consensus opinion and ensure that this MOP is practical and feasible.
All attempts to consider the context of local culture and practices have been taken in the creation of this MOP. Nonetheless, we have chosen to only define core aspects of the national AMS program without being overly prescriptive. Hospitals are strongly encouraged to adapt this MOP to their individual setting in order to maximize its effectiveness, including reduce barriers to implementation and encourage shared ownership towards the goal of AMS.
Antibiotic Stewardship: A National and International ImperativePYA, P.C.
J. Michael Keegan, MD, an infectious disease specialist who leads the antibiotic stewardship team at PYA, discussed antibiotic stewardship at the South Dakota Pharmacists Association’s (SDPHA) Annual Convention in Deadwood, South Dakota.
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...John Blue
Metrics and Decision-Making for Antibiotic Stewardship in Human Medicine - Dr. Steve Solomon, Centers for Disease Control & Prevention, Currently serves as Director of the Office of Antimicrobial Resistance in the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, in the Office of Infectious Diseases at CDC., from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Advisor Live: Advancing Antimicrobial StewardshipPremier Inc.
Fight antibiotic resistance! Join us and participate in Get Smart About Antibiotics Week 2016. Medical epidemiologist Dr. Kavita Trivedi will share her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.
- Current regulatory environment
- Implementation tools available
- Implementation challenges
Dr. Ceire Costelloe (Imperial College London) - Data-driven systems medicinemntbs1
The summary of Dr. Ceire Costelloe's presentation from the Jun 11-12th 2019 event Data-driven systems medicine at Cardiff University Brain Research Imaging Centre.
Role of PK PD in Antibiotic Stewardship Program with case study. This presentation gives an comprehensive overview about role of PK PD in antibiotic stewardship program.
Antibiotic Guardian Leeds Workshop 20164 All of Us
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics led an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology cover the current state of infectious disease management in the U.S., and what can be done to improve it.
You’ll learn about:
• The magnitude of the U.S. health system’s infectious disease management problem
• The most serious concerns and trends for healthcare institutions and communities across the nation
• The most promising solutions to health systems’ most urgent infectious disease management challenges
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Introduction: Bloodstream infections (BSIs) are associated with a high mortality rate of 20%-50%. Blood culture is paramount to identify causative agents of BSIs to choose an appropriate antimicrobial therapy. Objectives: The present study was undertaken to analyze the various microorganisms causing BSIs and study their antimicrobial resistance patterns in a tertiary care hospital, Eastern India. Materials and Methods: A total of 239 blood specimens from clinically suspected cases of BSIs were studied for 6 months from July 2015 to December 2015. Blood specimens were incubated in BacT/ALERT ® 3D system (bioMerieux, Durham, NC, USA) a fully automated blood culture system for detection of aerobic growth. Identification and antimicrobial susceptibility testing were conducted on VITEK ® 2 (bioMerieux, Durham, NC, USA) as per Clinical Laboratory Standards Institute guidelines. Results: Out of 239 specimens, 41 (17.2%) yielded growth of different microorganisms. From these isolates, 20 (48.8%) were Gram-negative bacilli, 18 (43.9%) were Gram-positive cocci and rest 3 (7.3%) were yeasts. Among Gram-negative bacilli, Klebsiella pneumoniae sub spp. pneumoniae (70%) was most commonly isolated. Coagulase-negative staphylococci (88.9%) were the most common isolate among Gram-positive cocci. All three Candida spp. isolated were nonalbicans Candida (two Candida tropicalis and one Candida krusei). Gram-negative isolates were least resistant to tigecycline and colistin. All Gram-positive cocci were sensitive to linezolid. Conclusion: Monitoring of data regarding the prevalence of microorganisms and its resistance patterns would help in currently prescribing antimicrobial regimens and improving the infection control practices by formulating policies for empirical antimicrobial therapy.
Effective Antimicrobial Susceptibility Testing; A path to solving AMR menace ...Hamidah Adekilekun
Antibiotic resistant is slowly reaching for the top as a public health threat. It is therefore important to keep educating and enlightening the public about this menace and solutions to defeat it
CDC Key Prevention Strategies for Antimicrobial Resistance Prevent Infection Step 1: Vaccinate Fact:
Influenza and pneumococcal vaccination of at-risk hospital patients and influenza vaccination of healthcare personnel will prevent infections.
Step 2: Get the catheters out Fact:
Catheters and other invasive devices are the # 1 exogenous cause of hospital-onset infections.
Diagnose & Treat Infection Effectively Step 3: Target the pathogen
Fact:
Appropriate antimicrobial therapy saves lives.
Step 4: Access the experts Fact:
Infectious diseases expert input improves the outcome of serious infections.
•
Use Antimicrobials Wisely
Step 5: Practice antimicrobial control Fact:
Programs to improve antimicrobial use are effective. (Antimicrobial Stewardship)
•
Step 6: Use local data
Fact:
The prevalence of resistance can vary by locality, patient population, hospital unit, and length of stay.
•
•
Step 7: Treat infection, not contamination Fact:
A major cause of antimicrobial overuse is “treatment” of contaminated cultures.
Step 8: Treat infection, not colonization Fact:
Step 9: Know when to say “no” to vancomycin Fact:
Vancomycin overuse promotes emergence, selection,and spread of resistant pathogens.
•
Step 10: Stop antimicrobial treatment Fact:
Failure to stop unnecessary antimicrobial treatment contributes to overuse and resistance.
Prevent Transmission
Step 11: Isolate the pathogen Fact:
Patient-to-patient spread of pathogens can be prevented.
•
Step 12: Break the chain of infection Fact:
Healthcare personnel can spread antimicrobial-resistant pathogens from patient to patient
Antimicrobial stewardship; is an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy…..
Why is Antimicrobial Stewardship Important?
200-300 million antibiotics are prescribed annually….45% for outpatient use
25-40% of hospitalized patients receive antibiotics
10-70% are unnecessary or suboptimal
5% of hospitalized patients who receive antibiotics experience an Adverse reaction.
Health insurance companies will no longer reimburse for hospital acquired conditions deemed preventable.
Why is an antibiotic policy necessary?
To improve patient care by considered use of antibiotics for prophylaxis and therapy.
To rationalize the use of antibiotics.
To prevent or retard the emergence of resistant strains.
To improve education of junior doctors by providing guidelines for appropriate therapy
What are the clinical uses of antibiotics :
1. Therapeutic use:-
It is administration of an antimicrobial agent where substantial microbial infection has occurred.
2. Prophylactic Use:-
It is the use of antimicrobial agent before any infection has occurred to prevent a subsequent infection.
The Antimicrobial Stewardship Program (ASP) should be administered by multidisciplinary team (AST) composed of:
an infectious diseases (ID)physician
a clinical pharmacist with ID training,
a clinical microbiologist,
an IC professional,
Antibioti
Antibiotic Stewardship: Current status and implications in IndiaJindal Chest Clinic
Antibiotic Stewardship: Current status and implications in India. This presentation gives an overview of Antibiotics: components, prescription, selection etc.
Similar to Providing Tools for a Healthier, More Abundant Quality of Life (20)
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Providing Tools for a Healthier, More Abundant Quality of Life
1. Health is the Greatest Gift;
Contentment, the Greatest Wealth
Providing Tools for a Healthier,
More Abundant Quality of Life
“Aging should
be a continued stage of development and
growth, rather than a period of decline.”
~The Eden Alternative
QoLQoL
2. Antimicrobial Stewardship In Nursing Homes
The Centers for Medicare and Medicaid Services (CMS) has finalized a new rule that requires
nursing homes to have an antibiotic stewardship program.
“The changes are aimed at improving the quality of care and strengthening safety measures for
residents, and reducing unnecessary hospital readmissions and infections. Nursing homes, skilled
nursing facilities, and assisted-living facilities must meet these new standards to receive
Medicare and Medicaid payments.” ~cms.gov
Residents are often frail and have underlying chronic conditions that make them more vulnerable
to infections, especially involving the skin, urinary tract, and respiratory tract. In addition,
bacterial infections tend to spread rapidly in these facilities because of patient proximity and
frequent nurse-resident contact.
QoL
3. Antimicrobial Stewardship in Long Term Care
What is antimicrobial stewardship?
Interventions designed to improve and
measure appropriate use of antimicrobials;
Selection of optimal antimicrobial drug and
regimen – dose, duration of therapy, route of
administration
Objectives are to achieve best clinical
outcomes related to antimicrobial use while:
Minimizing toxicity and other adverse
events, like C. difficile infection
Limiting selective pressure that drives
the emergence of antimicrobial resistance
Reducing excessive costs attributable
to suboptimal antimicrobial use
QoL
4. % of Antimicrobials
Prescribed in LTCF
Antimicrobials Other
Inappropriate
Antibiotic Prescriptions
Antibiotics Other
Why is antimicrobial stewardship important in long
term care (LTC)?
• 40% of all systemic drugs prescribed in LTC are
antimicrobials
• 25-75% of antibiotic prescriptions for LTC residents
are inappropriate
• Inappropriate use of antimicrobials increases C.
difficile infection, selection of multidrug-resistant
organisms, drug-drug interactions, and other
adverse events
• Risk for colonization and infection with antibiotic-
resistant organisms is high; residents travel between
healthcare facilities and the community
QoL
5. “The optimism of the early period of antimicrobial discovery has been tempered by the emergence
of bacterial strains with resistance to these therapeutics. Today, clinically important
bacteria are characterized not only by single drug resistance but also by multiple
antibiotic resistance — the legacy of past
decades of antimicrobial use and misuse. Drug
Resistance presents an ever-increasing global
public health threat that involves all major
microbial pathogens and antimicrobial drugs.”
The Impact of Antibiotic Resistance on the Outcome
and Costs of Patient Care
QoL
6. “Each year in the United States, at least 2 million people become
infected with bacteria that are resistant to antibiotics and at least
23,000 people die…”
Antibiotic Prescribing and Use Policies
High rates of infection, has raised the
concern that nursing homes are becoming a
significant reservoir of multidrug- resistant
bacteria in the community. And given that
long term care facility residents are
frequently transferred to acute care
facilities, those bugs can then spread into
healthcare settings.
QoL
7. Reduce Antibiotic Use in Asymptomatic Bacteriuria
(ASB)
The prevalence of ASB, bacteriuria without localizing signs or symptoms of infection, ranges from
25% to 50% in non-catheterized nursing home residents and up to 100% among those with
long-term urinary catheters. Antibiotic use for treatment of ASB in nursing home residents
does not confer any long-term benefits, and may actually increase the incidence of adverse drug
events and result in subsequent infections with antibiotic-resistant pathogens.
Suspected UTIs account for 30% to 60% of antibiotic prescriptions in nursing homes.
Implementing a set of diagnostic testing and management algorithms to
help providers differentiate ASB from symptomatic UTI has been shown to reduce
inappropriate antibiotic use for ASB.
QoL
“The unreliable clinical assessment for infections in nursing home
residents coupled with the diagnostic uncertainties in differentiating
ASB from infection contributes greatly to inappropriate antibiotic use.”
9. Outcomes Related to E. coli and K. pneumoniae
Infections with *ESBLs
9%
15%
0%
2%
4%
6%
8%
10%
12%
14%
16%
Mortality %
Negative ESBL Positive ESBL
$22,231
$65,590
$0
$10,000
$20,000
$30,000
$40,000
$50,000
$60,000
$70,000
Cost
Negative ESBL Positive ESBL
7
11
0
2
4
6
8
10
12
Length of Stay
Negative ESBL Positive ESBL
QoL
* Extended-spectrum β-lactamase (ESBL)
10. Outcomes Related to the Emergence of Cephalosporin
Resistant Enterobacter sp. (HAI)
13%
24%
0%
5%
10%
15%
20%
25%
30%
Mortality %
Resistance at Baseline
Emergence at Baseline
$43,456
$79,323
$0
$10,000
$20,000
$30,000
$40,000
$50,000
$60,000
$70,000
$80,000
$90,000
Cost
Resistance at Baseline
Emergence at Baseline
13
23
0
5
10
15
20
25
Length of Stay
Resistance at Baseline
Emergence at Baseline
QoL
11. 0 2 4 6 8 10 12 14 16 18
TOTAL NUMBER OF NEW
ANTIBACTERIAL AGENTS
2008-2012 2003-2007 1998-2002
1993-1997 1988-1992 1983-1987
“Diatherix and
Thermo Fisher are dedicated to
advancing education and support of
the antimicrobial stewardship
movement so that we may preserve
the effectiveness of existing
antibiotics both in the U.S. and
abroad. “
“Although antibiotics have been used to treat patients for
more than seven decades, we are now experiencing an
alarming emergence of antibiotic resistance. The relative
decline of new and novel antibiotics being introduced for
treating infections over the past two decades compounds
the precarious position that we now face.”
~Resistance: Policy Recommendations to Save Lives
QoL
12. Grace Medical is partnered with Diatherix Eurofins, a molecular diagnostic laboratory that
specializes in the diagnosis of infectious diseases. Their state of the art laboratory and R&D
division are located inside the HudsonAlpha Institute of Biotechnology, Huntsville, AL.
We provide solutions to aide your antibiotic stewardship and infectious disease control &
prevention programs. Our technology offers reporting that directly correlates to:
• Improved patient quality of life
• Reduced re-admissions
• Control & often prevention of HAIs
• Lowered, with potential to eliminate the
overuse and misuse of antibiotics
• Increased quality measures for improved star ratings
Diatherix Rapid Molecular DiagnosticsQoL
13. The Advantages of Molecular Diagnostics (MDx)
We provide a menu of molecular diagnostic panels that produce an actionable
treatment plan. Each panel, when paired with the antibiotic resistant panel (ABRx) ,
will provide physicians guidance as to proper antibiotic administration, thereby
improving therapeutic response and patient recovery time.
Advantages of MDx vs Culture:
• Next day reporting
• ABRx Panel provides guidance for appropriate antibiotic treatment
• Offers simplicity of single sample collection
• Ability to detect bacteria in the presence of an antibiotic
• Identifies difficult to culture Pathogens
QoL
14. • TEM-PCR™ technology is capable of
identifying bacteria, regardless of recent
antibiotic use
• Reduced antibiotic utilization and
inappropriate prescribing
• Identifies difficult to culture pathogens
• Improved patient outcomes
• Offers simplicity of single sample
collection
• Yields greater than 95% analytical
sensitivity and specificity
QoL
15. Commonly used panels in the LTCF Environment
PANEL PURPOSE (indications)
Antibiotic Resistance (ABRx™) Detection results can be used to define an
antibiotic class avoidance strategy
Respiratory (RPP) Bronchitis, Common Cold, Pharyngitis,
Sinusitis, Cough, Fever, Wheezing,
Pneumonia, Viral Infection
Skin and Soft Tissue (SSTI) Open Wound, Diabetic Foot, Bed Sores
Gastrointestinal (GI) Nausea with or without vomiting, Diarrhea,
Abdominal Pain, Fever, Blood in Stool,
Abnormal Loss of Weight, Colitis,
Gastroenteritis, Viral Enteritis
Urinary Tract Infection (UTI) Foul Smelling or Dark Urine, Frequent
Urination, Sense of Incomplete Bladder
Emptying, Blood in Urine, Fever, Pain in
Lower Abdominal Area, Sudden Change in
Behavior, Falls
QoL
*Complete 25+ panels available here
16. “The true meaning of life is to plant
trees, under whose shade you do not
expect to sit.”
- NELSON HENDERSON -
Enriching the Quality of Life of Our Seniors
Jeani Smith: 409.504.8032
Brian Milner: 903.360.9291
info@gracemedicalconsultants.com
Grace Medical Consultants
QoL